BELLUS HEALTH INC Chart calendar BELLUS Health Inc
bc7bdf9.ZnA-ha-fOwdhy0JpKB_VQ26mMdvnrUqp9Du67bmSO78.PilQ3JvpVH4tnx0Rf3miJljXfqHVziDkwlfCj8rNDtUQAQz23-p0NlajBw~dc653112649c835db7ed61be178ecd6f
Upcoming events on BELLUS Health Inc
No events available
Past events on BELLUS Health Inc
| 30/06/2023 16:30 | Annual General Meeting |
| 16/06/2023 16:30 | Extraordinary Shareholders Meeting - M&A Vote |
| 22/05/2023 16:30 | American Thoracic Society International Conference |
| 21/05/2023 20:15 | American Thoracic Society International Conference |
| 12/05/2023 21:01 | Q1 2023 Earnings Release |
| 21/03/2023 20:47 | Q4 2022 Earnings Release |
| 08/03/2023 15:30 | Cowen Health Care Conference |
| 26/02/2023 15:45 | American Academy of Allergy, Asthma & Immunology Meeting - A Phase 2b Study of the P2X3 Antagonist B |
| 26/02/2023 15:45 | American Academy of Allergy, Asthma & Immunology Meeting - A Phase 2b Study in Refractory Chronic Co |
| 30/11/2022 19:15 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 16/11/2022 08:00 | Jefferies London Healthcare Conference - Fireside Chat |
| 14/11/2022 21:01 | Q3 2022 Earnings Release |
| 18/10/2022 19:30 | CHEST Meeting |
| 12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 04/09/2022 19:30 | European Respiratory Society International Congress - Characteristics of Participants with Refractor |
| 04/09/2022 19:30 | European Respiratory Society International Congress - Efficacy in SOOTHE, A Phase 2b Trial of BLU-59 |
| 04/09/2022 19:30 | European Respiratory Society International Congress - Improvements in Awake Cough Frequency in SOOTH |
| 10/08/2022 21:30 | Interim 2022 Earnings Release |
| 11/07/2022 14:00 | William Blair Biotech Focus Conference |
| 08/06/2022 16:00 | Jefferies Healthcare Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,04 0,04 0% | 0,04 0,02 66.67% | 0,02 0,01 61.12% | 0,02 0,02 9.94% | 0,02 0,02 -7.96% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million CAD | Released Forecast Spread | -9,91 -8,77 -12.99% | -34,1 -30,5 -11.91% | -41,2 -43,9 6.14% | -93,3 -100 7% | -106 -108 1.86% |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 0,00 - | -34,5 -28,8 -19.51% | -39,7 -43,0 7.66% | -90,9 -99,9 8.99% | -104 -111 6.11% |
|
Net income Million CAD | Released Forecast Spread | 0,00 0,00 - | -34,5 -28,8 -19.51% | -39,7 -42,8 7.16% | -90,6 -99,6 9.01% | -104 -111 6.17% |
|
EPS CAD | Released Forecast Spread | -0,29 0,00 - | -0,73 -0,38 -94.15% | -0,68 -0,67 -0.43% | -1,15 -1,16 0.95% | -0,91 -0,99 8.76% |
| Announcement Date | 21/02/19 | 27/02/20 | 25/02/21 | 23/02/22 | 21/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,01 -5.48% | 0,01 0,01 -17.9% | 0,00 0,01 -19.16% | 0,01 0,01 -17.64% | 0,01 0,00 138.71% | 0,01 0,00 31.03% | 0,01 0,00 27.64% | 0,01 0,01 -2.31% | 0,00 0,00 18.02% |
|
EBIT Million CAD | Released Forecast Spread | -19,2 -13,6 -41.9% | -22,5 -20,2 -11.54% | -28,4 -24,5 -15.99% | -21,0 -28,2 25.43% | -19,8 -23,6 15.97% | -22,8 -24,0 5.27% | -30,6 -27,3 -12.26% | -29,6 -32,7 9.5% | -37,5 -32,9 -14.15% |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -19,0 -13,6 -39.69% | -22,3 -20,0 -11.27% | -28,5 -24,3 -16.98% | -19,0 -28,0 31.91% | -18,5 -23,1 19.63% | -23,9 -23,7 -0.93% | -32,8 -27,4 -20.09% | -24,9 -33,3 25.17% | -33,9 -31,3 -8.37% |
|
Net income Million CAD | Released Forecast Spread | -19,0 -13,6 -39.69% | -22,3 -20,0 -11.27% | -28,5 -24,3 -16.98% | -18,8 -27,9 32.63% | -18,6 -23,1 19.48% | -24,0 -23,9 -0.35% | -32,8 -27,8 -17.99% | -25,1 -34,0 26.22% | -33,9 -31,3 -8.29% |
|
EPS CAD | Released Forecast Spread | -0,24 -0,18 -32.37% | -0,29 -0,25 -12.99% | -0,36 -0,29 -24.94% | -0,23 -0,32 27.97% | -0,17 -0,24 30.31% | -0,23 -0,22 -3.16% | -0,27 -0,23 -15.05% | -0,21 -0,27 24.92% | -0,27 -0,25 -9.16% |
| Announcement Date | 10/05/21 | 11/08/21 | 10/11/21 | 23/02/22 | 11/05/22 | 10/08/22 | 14/11/22 | 21/03/23 | 12/05/23 |
| Today 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 14/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 15/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 14:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 23/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 06:00 | ARGENX SE: Q2 2024 Earnings Release |
| 29/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
